Racemic cis-bis-[bis-(pyrimidin-2-yl)amine-κN]bis(dicyanamido-κN1)iron(II) dihydrate: synthesis, crystal structure and Hirshfeld surface analysis.

The title compound, [Fe(C2N3)2(C8H7N5)2]·2H2O, has been synthesized solvothermally and characterized by single-crystal X-ray diffraction. The octa-hedral iron coordination polyhedron contains two di(pyrimidin-2-yl)amine ligands coordinated in a bidentate fashion, and two monodentate dicyanimido ligands, each coordinated via a terminal N atom, with the latter in a cis orientation. The ligand configuration about the iron atom is chiral, although the compound crystallizes as a racemic mixture: the Fe-N distances (> 2.07 Å) are characteristic of high-spin iron(II). In the crystal, an extensive series of N-H⋯N, O-H⋯N and O-H⋯O hydrogen bonds links the independent mol-ecular components into a three-dimensional framework. The H atoms of both water mol-ecules are disordered. The structure also features some π-π and anion-π inter-actions. The inter-molecular inter-actions were investigated by Hirshfeld surface analysis and two-dimensional fingerprint plots. Comparisons are made with some related compounds.

trans-Bis(2,2'-di-pyridyl-amine-κ2 N,N')-bis-(1,1,3,3-tetra-cyano-2-eth-oxy-propenido-κN)copper(II).

The title compound, [Cu(C9H5N4O)2(C10H9N3)2], was synthesized solvothermally. The complex exhibits a distorted octa-hedral coordination geometry. The CuII atom is located on an inversion centre. The distorted octahedral CuN6 coordination sphere is composed of bidentate 2,2'-dipyrid-ylamine in the equatorial sites while the axial sites are occupied by 1,1,3,3-tetra-cyano-2-eth-oxy-propenide ligands. In the crystal, N-H⋯N hydrogen bonding results in chains parallel to [010].

catena-Poly[[bis-(quinolin-8-amine-κ2 N,N')cadmium(II)]-µ-cyanido-κ2 N:C-[dicyanidonickel(II)]-µ-cyanido-κ2 C:N].

In the title compound, [CdNi(C9H8N2)2(CN)4] n , the Cd and Ni atoms both lie on centres of inversion in space group P21/c. The Cd atom is coordinated by two bidentate quinolin-8-amine ligands and by the N atoms of two cyano ligands, while the square planar Ni atom is coordinated by the C atoms of four cyano ligands. These units form a one-dimensional coordination polymer containing an (-NC-Ni-CN-Cd-) n backbone, and the coordination polymer chains are linked into a three-dimensional array by a combination of N-H⋯N and C-H⋯N hydrogen bonds, augmented by a π-π stacking inter-action.

Synthesis, crystal structure and Hirshfeld surface analysis of bis-{2-[(pyridin-2-yl)amino]-pyridinium} tetra-cyano-nickelate(II).

In the title mol-ecular salt, (C10H10N3)2[Ni(CN)4], the dihedral angle between the pyridine rings in the cation is 1.92 (13)° and the complete anion is generated by a crystallographic centre of symmetry. An intra-molecular N-H⋯N hydrogen bond occurs in the cation, which closes an S(6) ring. In the crystal, the components are linked by N-H⋯N and weak C-H⋯N hydrogen bonds, which generate chains propagating in the [101] direction. Weak aromatic π-π stacking inter-actions are also observed. A Hirshfeld surface analysis and two-dimensional fingerprint plots indicate that the most important contact types in the crystal packing are N⋯H/H⋯N, C⋯H/H⋯C and H⋯H with contributions of 37.2, 28.3 and 21.9%, respectively.

Bis[tris-(pyridin-2-yl)amine]-iron(II) tris-(di-cyano-methyl-idene)methane-diide.

In the title compound, [Fe{(C5H4N)3N}2][C{C(CN)2}3], both ions lie across centres of inversion, with the anion being statistically disordered over two sets of atomic sites having equal occupancy. The cation and anion have approximate and 32 symmetry, respectively, and the Fe-N bond lengths indicate low-spin FeII. A combination of two-centre C-H⋯N and three-centre C-H⋯(N)2 hydrogen bonds link the ions into complex sheets. Several low-occupancy water mol-ecules are present, whose H atoms could not be located: accordingly, the reflection data were subjected to the SQUEEZE procedure [Spek (2015 ▸). Acta Cryst. C71, 9-18].

Anti-proliferation effects of benzimidazole derivatives on HCT-116 colon cancer and MCF-7 breast cancer cell lines.

Benzimidazoles 1-4 were obtained using modified synthesis methods and studied for their ability to inhibit cell proliferation of colon cancer cell HCT-116 and breast cancer cell MCF-7 using MTT assays. In the HCT-116 cell line, benzimidazole 2 was found to have an IC50 value of 16.2 ± 3.85 µg/mL and benzimidazole 1 a value of 28.5 ± 2.91 µg/mL, while that for benzimidazole 4 was 24.08 ± 0.31 µg/mL. In the MCF-7 cell line, benzimidazole 4 had an IC50 value of 8.86 ± 1.10 µg/mL, benzimidazole 2 a value of 30.29 ± 6.39 µg/mL, and benzimidazole 1 a value of 31.2 ± 4.49 µg/mL. Benzimidazole 3 exerted no cytotoxicity in either of the cell lines, with IC50 values >50 µg/mL. The results suggest that benzimidazoles derivatives may have chemotherapeutic potential for treatment of both colon and breast cancers.